CJC-1295 (No DAC) + Ipamorelin is a dual-peptide research formulation designed for advanced laboratory investigation into growth hormone signaling pathways, endocrine communication systems, and peptide-mediated metabolic regulation. This combination pairs a Growth Hormone Releasing Hormone (GHRH) analog with a selective Growth Hormone Secretagogue (GHS), creating a widely studied synergistic peptide blend utilized in endocrine and neuroendocrine research models.
CJC-1295 (No DAC) is a synthetic GHRH analog commonly investigated for its interaction with pituitary receptors and its role in stimulating pulsatile growth hormone signaling. Unlike DAC-modified variants, the No DAC version is characterized by a shorter active duration, allowing researchers to study more natural hormone pulse dynamics and time-sensitive endocrine responses.
Ipamorelin is a selective ghrelin receptor agonist studied for its ability to stimulate growth hormone release through interaction with the Growth Hormone Secretagogue Receptor (GHS-R1a). Due to its receptor selectivity, Ipamorelin is frequently utilized in laboratory models examining endocrine pathway modulation and peptide-mediated hormone signaling.
When combined, CJC-1295 (No DAC) and Ipamorelin are commonly studied for their complementary interaction within growth hormone cascade pathways. Research investigations often focus on pituitary communication systems, IGF-1 signaling dynamics, metabolic regulation, anabolic pathway signaling, and coordinated endocrine response mechanisms.
This peptide blend has become a widely researched combination in studies involving hormonal feedback loops, neuroendocrine communication, recovery-related signaling pathways, and metabolic efficiency research.
Manufactured to high purity standards and supplied in lyophilized form for enhanced stability and analytical consistency, this peptide blend is intended exclusively for qualified laboratory and scientific research applications.
Product Details:
Peptides: CJC-1295 (No DAC) + Ipamorelin
Peptide Type: GHRH Analog + Growth Hormone Secretagogue (GHS)
Purity: ≥98%
Form: Lyophilized powder
Quantity: 10mg CJC-1295 (No DAC) / 10mg Ipamorelin per vial
Grade: Research-grade. Intended for laboratory use only.
Potential Research Applications:
- Growth hormone signaling pathway studies
- Pituitary receptor interaction research
- Ghrelin receptor and GHS-R1a investigations
- IGF-1 signaling pathway analysis
- Hormonal feedback loop and endocrine cascade research
- Neuroendocrine communication studies
- Metabolic regulation and energy balance investigations
- Cellular repair and anabolic signaling pathway research
- Multi-peptide endocrine synergy models
- Pulsatile hormone release dynamics research
Research & Handling Information:
This peptide blend is supplied as a lyophilized research compound intended strictly for laboratory and analytical applications. Lyophilized peptides are commonly utilized in research environments due to their enhanced stability, long-term preservation characteristics, and consistency during controlled preparation procedures.
Researchers should follow all accepted peptide handling, storage, and analytical preparation protocols to maintain product integrity and research consistency.
For laboratory research use only. This product is not intended for human consumption or for the diagnosis, treatment, cure, or prevention of any disease.
